Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04774471 · ClinicalTrials.gov registry record
Advanced Diffusion Tensor MRI for Breast Cancer
A clinical trial, sponsored by Endeavor Health.
- Completed
- Registry status
- 68
- Enrollment target
NCT04774471: Completed study, sponsored by Endeavor Health.
NCT04774471 is a clinical trial that has completed, run by Endeavor Health. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04774471 has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate the accuracy of the BIT-Motion (Breast Imaging Tensor-Motion) software with non-contrast MRI scanning to detect breast cancer.
Primary Outcome
MRI scans evaluated with BIT-Motion software will be compared to definitive pathologic diagnosis
Interventions
- DIAGNOSTIC_TEST Evaluation of BIT-Motion software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2021-02-03 |
| Est. Completion | 2023-05-18 |
What the finished NCT04774471 record still lists
NCT04774471 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Evaluation of BIT-Motion software is the first listed.
NCT04774471 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04774471 about?
NCT04774471 is a clinical study titled "Advanced Diffusion Tensor MRI for Breast Cancer". The purpose of this research is to evaluate the accuracy of the BIT-Motion (Breast Imaging Tensor-Motion) software with non-contrast MRI scanning to detect breast cancer.
What is the current status of trial NCT04774471?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2021-02-03. Estimated completion is 2023-05-18.
What interventions are being tested in trial NCT04774471?
The interventions under investigation include: Evaluation of BIT-Motion software (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04774471?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI